Intraneuronal Aβ: Was It APP All Along?
secrete Aβ has stood the test of time and drawn the field’s main focus firmly to the outside of neurons
Upcoming Webinars
No Upcoming Webinars AvailableALL WEBINARS
151 RESULTS
You searched herpes-simplex-and-alzheimers-time-thinkagain
Sort By:
- Most Recent
- Most Commented
- Most Relevant
Two New Sets of Diagnostic Criteria—Which Is Right for Your Clinic?
On 19 April 2011, the National Institute on Aging (NIA) and the Alzheimer’s Association (AA)
Volunteers Help Scientists Explore Down’s, Alzheimer’s Nexus
more amyloid-β peptide in their brains than normal and, in time, they all develop Alzheimer
Grasping the Shadow Force: Immune Cells in ALS
Alzheimer’s disease. There, microglia cluster around amyloid-β plaques (Naert and Rivest, 2011). One and the
Reimagining Alzheimer's Disease—Time for Bright New Ideas?
Jersey, believes that the time has come to reassess what we know about AD, focusing less on amyloid and
Herpes Simplex and Alzheimer’s—Time to Think Again?
work on herpes simplex virus type 1 (HSV1) and Brian Balin ’s data showing induction of amyloid plaques
Stress Granules and Neurodegenerative Disease—What’s the Scoop?
sclerosis and frontotemporal lobar degeneration, where stress granule markers decorate pathological protein
Focus on the Locus! (Ceruleus, That Is, in Alzheimer’s Disease)
hippocampus and cortex have grabbed the lion’s share of attention in Alzheimer’s disease, leaving other brain
The AD8—Dementia Screen Ready for Prime Time?
the clinical dementia rating scale and against neuropsychological tests, and is available in several
Untapped Resource? New Study to Boost Acceptance of CSF Analysis
most of the Americas, parts of Europe, and Asia. For Alzheimer disease, amyloid imaging with PET
Microdissection and Microarrays: Analyzing Selective Cell Vulnerability
in its own way.” The same might be said of the brain. Normal brains look and behave similarly, but
Together at Last, Top Five Biomarkers Model Stages of AD
background in AD biomarker studies, or for those who simply had no time to absorb the 10-page article and its
New Models for Integrative Care of Alzheimer Disease
for the discussion were Pierre Tariot (Banner Alzheimer's Institute), John Ringman (UCLA), and
Treating Before Symptoms—ADCS Invites Ideas for Clinical Trials in Very Early AD
Carrillo, who directs medical and scientific relations at the Alzheimer’s Association, a funding
Of Mice and Men: Bridging the Translational Disconnect in CNS Drug Discovery
patients in the context of drug discovery with special emphasis on Alzheimer disease and schizophrenia,
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.